Ret Proto-Oncogene Antikörper (AA 29-635)
-
- Target Alle Ret Proto-Oncogene (RET) Antikörper anzeigen
- Ret Proto-Oncogene (RET)
-
Bindungsspezifität
- AA 29-635
-
Reaktivität
- Human, Maus
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Ret Proto-Oncogene Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Flow Cytometry (FACS)
- Spezifität
- Recognizes human Ret. Species cross-reactivity: Mouse.
- Aufreinigung
- Protein G purified
- Immunogen
-
Recombinant protein corresponding to aa29-635 from human Ret/Fc Chimera expressed in Sf21 cells (P07949).
Type of Immunogen: Recombinant protein - Isotyp
- IgG1
- Top Product
- Discover our top product RET Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA (0.5 - 1 μg/mL), Flo (50 μg/mL), WB (1 - 2 μg/mL)
Usage: Suitable for use in Flow Cytometry, Western Blot and Direct ELISA. Flow Cytometry: 50 μg/mL, For intracellular staining to detect human Ret, cells must first be fixed and permeabilized using 4 % paraformaldehyde and 0.1 % saponin. Dilute this antibody to 50 μg/mL and add 10 μL of the diluted solution to 1-2.5x10^5 cells in a total reaction volume not exceeding 200 μL. The binding of unlabeled monoclonal antibodies may be visualized by adding 10 μL of a 25 μg/mL stock solution of a secondary developing reagent such as goat anti-mouse IgG conjugated to a fluorochrome. Cells should be washed for a final time in 0.1 % saponin prior to flow cytometric analysis. Western Blot: 1-2 μg/mL, Detection limit for rhRet is ~50 ng/lane under non-reducing and reducing conditions. Use chemiluminescence to increase sensitivity. Direct ELISA: 0.5-1.0 μg/mL, The detection limit for rhRet and rmRet is ~6 ng/well. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute with sterile PBS to a concentration of 0.5 mg/mL.
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS, 5 % trehalose.
- Handhabung
- Avoid freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. After reconstitution, aliquot and store at -20°C. Avoid freeze/thaw cycles.
-
- Target
- Ret Proto-Oncogene (RET)
- Andere Bezeichnung
- RET (RET Produkte)
- Synonyme
- c-ret antikoerper, cret antikoerper, etID315074.13 antikoerper, ret1 antikoerper, wu:fd13h01 antikoerper, X-ret antikoerper, ret-A antikoerper, xret antikoerper, RET antikoerper, MTC1 antikoerper, CDHF12 antikoerper, CDHR16 antikoerper, HSCR1 antikoerper, MEN2A antikoerper, MEN2B antikoerper, PTC antikoerper, RET-ELE1 antikoerper, RET51 antikoerper, RET9 antikoerper, c-Ret antikoerper, ret proto-oncogene receptor tyrosine kinase antikoerper, ret proto-oncogene S homeolog antikoerper, ret proto-oncogene antikoerper, ret antikoerper, ret.S antikoerper, RET antikoerper, Ret antikoerper
- Hintergrund
-
Name/Gene ID: RET
Subfamily: Cadherin
Family: Protein Kinase
Synonyms: RET, Cadherin family member 12, CDHF12, C-ret, Hirschsprung disease 1, HSCR1, Hydroxyaryl-protein kinase, Oncogene ret, Proto-oncogene c-Ret, RET-ELE1, RET51, Ret proto-oncogene, RET transforming sequence, RET43, Men2-ret, MEN2B, MTC1, Receptor tyrosine kinase, CDHR16, MEN2A, PTC, RET9 - Gen-ID
- 5979
- UniProt
- P07949
- Pathways
- RTK Signalweg, Dopaminergic Neurogenesis, Regulation of Cell Size, Tube Formation
-